切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (02) : 205 -208. doi: 10.3877/cma.j.issn.1674-3946.2023.02.023

论著

SME+D2全胃切除术在进展期胃癌中的临床研究
魏世东1,(), 孙劲文1   
  1. 1. 100028 北京,应急总医院普外肿瘤科
  • 收稿日期:2022-06-02 出版日期:2023-04-26
  • 通信作者: 魏世东

Clinical study of SME+D2 total gastrectomy in advanced gastric cancer

Shidong Wei1,(), Jinwen Sun1   

  1. 1. Department of General Surgery and Oncology, Emergency General Hospital, Beijing 100028, China
  • Received:2022-06-02 Published:2023-04-26
  • Corresponding author: Shidong Wei
引用本文:

魏世东, 孙劲文. SME+D2全胃切除术在进展期胃癌中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(02): 205-208.

Shidong Wei, Jinwen Sun. Clinical study of SME+D2 total gastrectomy in advanced gastric cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(02): 205-208.

目的

对比研究腹腔镜下系统性胃系膜切除术(SME)+D2全胃切除术与标准的腹腔镜D2全胃切除术在进展期胃癌中的应用效果。

方法

选取2018年1月至2020年12月70例行腹腔镜全胃切除术(LTG)治疗的进展期胃癌患者作为研究对象,采用随机数字表法将患者分SME组和标准组,每组各35例。SME组采用基于SME下腹腔镜全胃切除术+D2淋巴结清扫术;标准组采用腹腔镜全胃切除术+D2淋巴结清扫术。数据应用软件SPSS 22.0处理,患者围手术期相关指标等计量资料采用(

xˉ
±s)表示,行独立样本t检验;术后并发症情况等计数资料采用率(%)表示,行χ2检验;生存分析采用Kaplan-Meier法并行Log-Rank检验。P<0.05表示差异有统计学意义。

结果

SME组患者手术时间、术中出血量、术后首次排气时间、首次进食时间及术后住院时间显著低于标准组,淋巴结清扫数目显著高于标准组,差异均有统计学意义(P<0.05)。两组患者术后并发症的总发生率比较(20.0% vs. 14.3%),差异无统计学意义(P>0.05)。随访期间,通过Kaplan-Meier分析显示,标准组和SME组累积总生存率(68.6% vs. 85.7%)及无病生存率(65.7% vs. 82.9%)比较,差异有统计学意义(Log-Rank χ2=4.068、4.587,P=0.044、0.032)。

结论

与标准的D2全胃癌切除术相比,SME+D2全胃切除术不仅缩短了手术时间,减少了术中出血量,更有利于患者术后恢复,未增加手术风险的发生,而且使淋巴结清扫更彻底,更有利于提高患者预后,获得了更好的手术疗效,值得推广应用。

Objective

To compare the efficacy of laparoscopic systemic mesangectomy(SME)+D2 total gastrectomy with standard laparoscopic D2 total gastrectomy in patients with advanced gastric cancer.

Methods

Seventy patients with advanced gastric cancer who underwent laparoscopic total gastrectomy(LTG)from January 2018 to December 2020 were selected as the study objects. The patients were divided into SME group and standard group by random number table method,with 35 cases in each group. SME group:Laparoscopic total gastrectomy +D2 lymph node dissection based on SME,standard group:laparoscopic total gastrectomy +D2 lymph node dissection. The data was processed by SPSS 22.0 software. Measurement data such as perioperative indicators were represented by(

xˉ
±s),and independent sample t test was performed. The adoption rate of counting data such as postoperative complications(%),χ2 test was performed;Survival analysis was performed by Kaplan-Meier method and Log-Rank test. P<0.05 indicated statistically significant difference.

Results

The operative time,intraoperative blood loss,first postoperative exhaust time,first eating time and postoperative hospital stay in SME group were significantly lower than those in standard group,and the number of lymph nodes dissection was significantly higher than that in standard group,with statistical significance(P<0.05). There was no significant difference in the total incidence of postoperative complications between the two groups(20.0% vs.14.3%)(P>0.05). During the follow-up period,Kaplan-Meier analysis showed that the cumulative overall survival rate(68.6% vs.85.7%)and disease-free survival rate(65.7% vs.82.9%)between the standard group and the SME group were significantly different(Log-Rank χ2=4.068,4.587,P=0.044,0.032).

Conclusion

Compared with the standard D2 total gastrectomy,SME+ D2 total gastrectomy not only reduces the operation time,reduces intraoperative blood loss,is more conducive to postoperative recovery of patients,and does not increase the occurrence of surgical risks,but also enables more thorough dissection of lymph nodes,is more conducive to improving the prognosis of patients,and achieves better surgical efficacy,which is worthy of popularization and application.

表1 70例进展期胃癌行LTG不同术式两组患者一般资料[(
xˉ
±s),例]
表2 70例进展期胃癌行LTG不同术式两组患者围手术期相关指标比较[(
xˉ
±s),例]
表3 70例进展期胃癌行LTG不同术式两组患者术后并发症情况比较[例(%)]
图1 70例进展期胃癌行LTG不同术式两组患者术后累积生存曲线
[1]
Machlowska JBaj JSitarz M,et al. Gastric cancer:epidemiology,risk factors,classification,genomic characteristics and treatment strategies[J]. Int J Mol Sci202021(11):4012.
[2]
刘凤林,秦新裕. 胃癌根治术现状与展望[J]. 中国普外基础与临床杂志201926(07):769-771.
[3]
Tokunaga MSato YNakagawa M,et al. Perioperative chemotherapy for locally advanced gastric cancer in Japan:current and future perspectives[J]. Surg Today202050(1):30-37.
[4]
吴培,孙克康,伊西磊. 腹腔镜辅助全胃切除术联合D2淋巴结清扫术在进展期胃癌治疗中的应用[J/CD]. 中华普外科手术学杂志(电子版)201913(06):628-630.
[5]
Shinohara HKurahashi YIshida Y. Gastric equivalent of the 'Holy Plane' to standardize the surgical concept of stomach cancer to mesogastric excision:updating Jamieson and Dobson's historic schema[J]. Gastric Cancer202124(2):273-282.
[6]
毕然,魏玉哲,王宽. “双眼看世界”——腹腔镜胃癌根治术膜解剖复制体会与思考[J]. 中华胃肠外科杂志201922(05):418-422.
[7]
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018(5th edition)[J]. Gastric Cancer202124(1):1-21.
[8]
李敏哲,沈荐,杜燕夫,等. 进展期胃癌腹腔镜辅助与开腹全胃D2根治术临床疗效的比较[J]. 中国微创外科杂志201717(07):589-593.
[9]
韩方海,杨斌. 解读第15版日本胃癌处理规约[J]. 中华胃肠外科杂志201821(04):409-412.
[10]
徐惠绵,王鑫. 我国胃癌诊治临床研究现状与展望[J]. 中华胃肠外科杂志202023(02):109-114.
[11]
Tang SLiu FLi Y,et al. Treatment selection and survival outcomes in locally advanced proximal gastric cancer:a national cancer data base analysis[J]. Front Oncol202010:537051.
[12]
王向征,赵宗耀,张会来,等. 淋巴结清扫范围对进展期胃癌患者预后的影响研究[J]. 癌症进展201917(08):929-932.
[13]
Tonouchi ASugano MTokunaga M,et al. Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer[J]. World J Surg201943(10):2499-2505.
[14]
解亦斌,邵欣欣,丁世康,等. 重视精准医学时代下胃系膜外科学的研究[J]. 中华医学杂志2022102(12):827-829.
[15]
许淑镇,丁志杰,袁思波,等. 腹腔镜辅助自然腔道取标本系统性胃系膜切除术治疗胃下部癌的应用初探[J]. 中华胃肠外科杂志201922(05):479-483.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[8] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[9] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[10] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[11] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[12] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要